Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.45 USD | +1.10% | +1.26% | +513.39% |
May. 09 | Landos Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+513.39% | 70.18M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+50.18% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- LABP Stock
- News Landos Biopharma, Inc.
- Landos Biopharma Enters Research Collaboration to Investigate Effects of NX-13 on Epithelial Cells